|
|
|
|
|
by forgotpwagain
460 days ago
|
|
It is worth mentioning that China is heavily investing in biotechnology and they are getting genuinely good at the more commodified parts of the industry. This blog post [1] is long and aimed at a biotech expert audience, but one summary line that stands out is that "the drug industry is having its own DeepSeek Moment" [2]. To that end, I believe that this is the time to invest in the US biotechnology ecosystem so that we remain competitive with China. The ongoing crisis at the NIH is antithetical to this goal, as Derek Lowe's blog posts describe. [1] https://centuryofbio.com/p/commoditization
[2] https://www.wsj.com/health/pharma/the-drug-industry-is-havin... |
|
I also reject the notion that progress is a zero-sum game, that we have to "compete" at all, that there needs to be a winner and a loser here. We could just as well work with others to improve the lives of us and our communities. Why isn't the notion "cooperate with China to uplift all"? Perhaps releasing your models under a MIT license is actually the right move here that is in everyone's best interest, perhaps the US should be following their lead?